Inactive Instrument
BioForce Nanosciences Holdings, Inc. Stock Other OTC
Stocks
BFNH
US09064C2061
Other Specialty Retailers
OTC Markets Traded| Market Cap | 61.73M 53.58M 50.16M 45.89M 86.51M 5.87B 87.8M 587M 230M 2.94B 232M 227M 9.78B | P/E 2024 |
-20.4x | P/E 2025 | -14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 61.83M 53.66M 50.24M 45.97M 86.65M 5.88B 87.95M 588M 231M 2.94B 232M 227M 9.8B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
19.02% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +28.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Kaiser
CEO | Chief Executive Officer | 61 | 17/06/2026 |
Merle Ferguson
PSD | President | 79 | 01/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Merle Ferguson
CHM | Chairman | 79 | 08/07/2013 |
Richard Kaiser
BRD | Director/Board Member | 61 | 01/07/2013 |
Scott Mager
BRD | Director/Board Member | - | 15/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +28.57% | -.--% | - | - | 61.73M | ||
| +2.69% | +7.86% | +159.85% | - | 1.12B | ||
| +1.60% | -1.58% | -9.51% | +149.12% | 736M | ||
| +0.46% | +2.96% | -48.03% | +213.54% | 539M | ||
| -0.82% | +13.95% | +0.63% | - | 78.48M | ||
| Average | +6.50% | +3.30% | +25.73% | +181.33% | 619.42M | |
| Weighted average by Cap. | +2.42% | +2.18% | +59.30% | +176.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -490K -426K -399K -365K -687K -46.65M -698K -4.66M -1.83M -23.36M -1.84M -1.8M -77.71M | -1.29M -1.12M -1.05M -960K -1.81M -123M -1.84M -12.28M -4.82M -61.53M -4.85M -4.75M -205M |
| Net Debt | 273K 237K 222K 203K 383K 25.99M 389K 2.6M 1.02M 13.01M 1.03M 1M 43.29M | 101K 87.23K 81.67K 74.72K 141K 9.56M 143K 955K 375K 4.79M 377K 369K 15.92M |
Employees
-
Sector
Other Specialty Retailers
















